21 July 2020: PIB Summary & Analysis

July 21st, 2020 PIB:- Download PDF Here

Product banner


1. India Ideas Summit
2. Sero-prevalence study conducted by National Centre for Disease Control

1. India Ideas Summit


PM to deliver the keynote address at India Ideas Summit on 22 July.

About the India Ideas Summit:

  • The Summit is being hosted by the US-India Business Council.
  • This year marks the 45th anniversary of the formation of the Council.
  • The theme for this year’s Summit is ‘Building a Better Future’.
  • The virtual Summit will feature high-level presence from Indian and US government policymakers, state-level officials, and thought leaders from business and society.
  • The Summit will witness discussions on areas including India-US cooperation and the future of the relation between the two counties in a post-pandemic world.

About the US-India Business Council (USIBC):

  • The USIBC was formed in 1975 as a business advocacy organization to enlighten and encourage the private sectors of both India and the United States to enhance investment flows.
  • The organization serves as a direct link between business and Government leaders, resulting in increased trade and investment to strengthen ties between the two nations.
  • Is partners with major Indian trade associations such as the CII, FICCI, NASSCOM, etc.

2. Sero-prevalence study conducted by National Centre for Disease Control


The Ministry of Health and Family Welfare (MoHFW) commissioned a sero-surveillance study in Delhi.


  • This study has been done by the National Centre for Disease Control (NCDC) in collaboration with Govt. of the National Capital Territory of Delhi, following a rigorous multi-stage sampling study design.
  • The study was conducted from 27th of June 2020 to 10th July 2020.
  • For all the 11 districts of Delhi, survey teams were formed.
  • Blood samples were collected from selected individuals after taking written informed consent and then their sera were tested for IgG antibodies and infection using COVID KAVACH ELISA.
  • It is one of the largest sero-prevalence studies conducted in the country using the ELISA testing.
  • 21,387 samples were collected as per lab standards and were tested.
  • The tests help in identifying the of presence of antibodies in the general population.
  • These tests performed are not diagnostic tests but only provides information about past infection due to SARS-CoV-2 in individuals who test positive.
  • Antibody testing repeatedly done over time i.e. sero-surveillance, generates important evidence for assessing the spread of the pandemic from time to time.

What do the results show?

  • The results of the sero-prevalence study show that on an average, across Delhi, the prevalence of IgG antibodies is 23.48 %.
  • The study also indicates that a large number of infected persons remain asymptomatic.

What is sero-prevalence?

  • Sero-prevalence is the number of persons in a population who test positive for a specific disease based on serology (blood serum) specimens.
  • It is often presented as a percent of the total specimens tested or as a proportion per 100,000 persons tested.
  • As positively identifying the occurrence of the disease is usually based upon the presence of antibodies for that disease (especially with viral infections such as Herpes Simplex, HIV, and SARS-CoV-2), this number is not significant if the specificity of the antibody is low.

About the National Centre for Disease Control (NCDC):

  • The organisation was established to function as a national centre of excellence for control of communicable diseases.
  • It works under the Directorate General of Health Services, Ministry of Health & Family Welfare, GOI.
  • It was formerly known as the National Institute of Communicable Diseases (NICD).
  • Its origins can be traced back to the Central Malaria Bureau, formed in 1909 in Kasauli. It was renamed as the Malaria Survey of India in 1927.
  • In 1938, it shifted to Delhi under the name Malaria Institute of India (MII). In 1963, the MII became the NICD.
  • NCDC Functions:
    • Trained health manpower development: carries out various training programmes in the field of communicable diseases.
    • Applied research: in various fields such as bacteriology, virology, mycology, immunology, parasitology, studies of epidemic-prone diseases, transmission dynamics of diseases, studies on pesticides’ biological hazards, etc.
    • Specialised services: diagnostics, storage and supply of diagnostic reagents, entomological services, quality control of insecticides, outbreak investigations, etc.
    • Publications: bringing out regular newsletters and other material disseminating valuable information about any event of public health importance.
  • NCDC’s main centre is n Delhi, and it has branches in many other locations in India.

July 21st, 2020 PIB:- Download PDF Here

Leave a Comment

Your Mobile number and Email id will not be published. Required fields are marked *